文献速递头颈部肿瘤放疗姑息放疗与转移瘤

原发灶不明颈部淋巴结转移的放射治疗管理:现代放疗技术治疗大队列的经验

Radiotherapeutic management of cervical lymph node metastases from an unknown primary site - experiences from a large cohort treated with modern radiation techniques.
PubMed 文献 · Radiat Oncol · 2020-04-15

该单中心回顾性分析纳入2008至2019年在弗莱堡大学医学中心接受(化)放疗的58例原发灶不明颈部淋巴结转移(CCUP)患者,中位随访29.9个月。全咽及颈部淋巴结放疗伴危险因素时同步化疗显示良好的局部区域控制,但异时性远处转移限制生存,需进一步解决。

要点

  • 局部区域复发7例(12.1%),远处转移13例(22.4%)。
  • 吸烟与生存下降显著相关(p<0.05),pN3有OS受损趋势(p=0.07)。

核心结论

  • 全咽及颈部淋巴结放疗并在有危险因素时同步化疗,局部区域控制良好,但异时性远处转移限制生存,须进一步解决。

研究设计与样本

  • 单中心回顾性分析纳入2008至2019年弗莱堡大学医学中心58例接受(化)放疗的CCUP患者。
  • 采用Kaplan-Meier法计算OS、局部区域PFS和DMFS,Cox回归分析诊断性操作对肿瘤结局的影响,并量化治疗相关毒性。

主要发现

  • 中位随访29.9个月(范围4.6-121.9)。
  • 21例(36.2%)接受根治性放疗,35例(60.3%)接受辅助放疗,2例(3.4%)针对寡转移性疾病治疗。
  • 40例(69.0%)接受同步化疗;89.6%完成预定放疗,65.0%完成预定同步化疗。
  • 局部区域复发7例(12.1%),远处转移13例(22.4%)。

临床怎么用

  • 对CCUP患者可采用全咽及颈部淋巴结放疗,有危险因素时联合同步化疗。
  • 治疗中需关注吸烟对生存的不良影响及pN3的预后趋势。
  • 需监测并管理放射性皮炎和黏膜炎等毒性。

局限性

  • 单中心回顾性设计,样本量58例,证据等级有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To analyze management and outcomes following (chemo)radiation therapy in patients with cervical lymph node metastases from an unknown primary site (CCUP) in a large single-center cohort. METHODS: Between 2008 and 2019, 58 patients with CCUP were treated with (chemo)radiation therapy at the University of Freiburg Medical Center and were included in this analysis. Overall survival (OS), locoregional progression-free survival (PFS) and distant metastasis-free survival (DMFS) were calculated using the Kaplan-Meier method. The use of diagnostic procedures and their impact on oncological outcomes was analyzed by Cox regression, and treatment-related toxicities were quantified. RESULTS: Median follow-up was 29.9 months (range 4.6-121.9). Twenty-one patients (36.2%) received definitive RT, 35 (60.3%) underwent adjuvant RT, and 2 (3.4%) were treated for oligometastatic disease. Concurrent chemotherapy was prescribed in 40 patients (69.0%). 89.6% of patients completed the prescribed RT, and 65.0% completed the prescribed simultaneous chemotherapy. Locoregional recurrence was observed in 7 patients (12.1%) and distant metastases in 13 cases (22.4%). OS was 81,1, 64.9% and 56,6% after 1, 3 and 5 years, respectively. Univariate analysis of age, gender, extracapsular spread, tumor grading, neck dissection, diagnostic utilization of 18F-fluorodeoxyglucose positron-emission tomography and concomitant chemotherapy showed no effect on OS (p > 0.05 for all), while smoking was significantly associated with decreased survival (p < 0.05). There was a trend towards impaired OS for patients with advanced nodal status (pN3) (p = 0.07). Three patients (5.2%) experienced grade 3 radiation dermatitis, and 12 (22.4%) developed grade 3 and 1 (1.7%) grade 4 mucositis. CONCLUSIONS: RT of the panpharynx and cervical lymph nodes with concurrent chemotherapy in case of risk factors demonstrated good locoregional control, but the metachronous occurrence of distant metastases limited survival and must be further addressed.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Sprave T, Rühle A, Hees K, et al. Radiotherapeutic management of cervical lymph node metastases from an unknown primary site - experiences from a large cohort treated with modern radiation techniques. Radiat Oncol. 2020. PMID: 32293497. doi:10.1186/s13014-020-01529-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。